(R)-ACX, a pancreatic beta-cell selective sulfonylurea, does not aggravate myocardial ischemia-reperfusion damage.
Namekata I, Yamaguchi Y, Moriguchi S, Yamazaki S, Terasawa A, Yamagishi R, Aikawa T, Saito T, Kurashima K, Seri K, Imamura Y, Akita H, Shigenobu K, Tanaka H.
Namekata I, et al.
Eur J Pharmacol. 2007 Dec 22;577(1-3):211-8. doi: 10.1016/j.ejphar.2007.09.012. Epub 2007 Sep 26.
Eur J Pharmacol. 2007.
PMID: 17927975